Making individualized decisions in the midst of uncertainties: The case of prostate cancer and biochemical recurrence

European Urology

Volumn 64, Issue 6, 2013, Pages 916-918

  Chen, Ronald C ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANDROGEN DEPRIVATION THERAPY; BIOCHEMICAL RECURRENCE FREE SURVIVAL; BRACHYTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; COMORBIDITY; CONSERVATIVE TREATMENT; CONSULTATION; EDITORIAL; EXTERNAL BEAM RADIOTHERAPY; HUMAN; LIFE EXPECTANCY; LONG TERM CARE; MEDICAL SPECIALIST; MORBIDITY; OVERALL SURVIVAL; PATHOPHYSIOLOGY; PATIENT DECISION MAKING; PATIENT PREFERENCE; PHYSICIAN; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; RISK FACTOR; SALVAGE THERAPY; TREATMENT OUTCOME; TREATMENT RESPONSE; UNCERTAINTY; URINARY FREQUENCY;

HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; PROSTATIC NEOPLASMS;

EID: 84887405951     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2013.07.001     Document Type: Editorial

References (10)

1. S. Punnen, M.R. Cooperberg, and A.V. D'Amico Management of biochemical recurrence after primary treatment of prostate cancer: a systematic review of the literature Eur Urol. 64 2013 905 915
2. B.J. Trock, M. Han, and S.J. Freedland Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy JAMA 299 2008 2760 2769
3. A.J. Stephenson, S.F. Shariat, and M.J. Zelefsky Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy JAMA 291 2004 1325 1332
4. I.M. Thompson, C.M. Tangen, and J. Paradelo Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial J Urol 181 2009 956 962
5. M. Bolla, H. van Poppel, and B. Tombal Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911) Lancet 380 2012 2018 2027
6. T. Wiegel, D. Bottke, and U. Steiner Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95 J Clin Oncol 27 2009 2924 2930
7. K.E. Hoffman, P.L. Nguyen, and M.H. Chen Recommendations for post-prostatectomy radiation therapy in the United States before and after the presentation of randomized trials J Urol 185 2011 116 120
8. A.J. Stephenson, M. Bolla, and A. Briganti Postoperative radiation therapy for pathologically advanced prostate cancer after radical prostatectomy Eur Urol 61 2012 443 451
9. N.C. Sheets, L.H. Hendrix, I.M. Allen, and R.C. Chen Trends in the use of postprostatectomy therapies for patients with prostate cancer Cancer. 119 2013 3295 3301
10. C.M. Moinpour, K.A. Hayden, and J.M. Unger Health-related quality of life results in pathologic stage C prostate cancer from a Southwest Oncology Group trial comparing radical prostatectomy alone with radical prostatectomy plus radiation therapy J Clin Oncol 26 2008 112 120